Title of article
Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial
Author/Authors
Ulrike Anneliese Nitz، نويسنده , , Svjetlana Mohrmann، نويسنده , , Johannes Fischer، نويسنده , , Walter Lindemann، نويسنده , , Wolfgang E Berdel، نويسنده , , Christian Jackisch، نويسنده , , Christoph Werner، نويسنده , , Carsten Ziske، نويسنده , , Hartmut Kirchner، نويسنده , , Bernd Metzner، نويسنده , , Rainer Souchon، نويسنده , , Ute Ruffert، نويسنده , , Gerhart Schutt، نويسنده , , Anke Pollmanns، نويسنده , , Hans Joach، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2006
Pages
10
From page
1935
To page
1944
Abstract
Background
Breast cancer with extensive axillary-lymph-node involvement has a poor prognosis after conventional treatment. In trials with historical controls, high-dose chemotherapy produced improved outcomes. We compared an intensive double-cycle high-do
Journal title
The Lancet
Serial Year
2006
Journal title
The Lancet
Record number
588971
Link To Document